Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
WES analysis led to the identification of a new pathogenic variant in the SLC19A2 gene (c.596C>G, pSer199Ter) allowing to identify the young boy as a TRMA patient.
|
31144472 |
2019 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The novel mutation described here extends the list of SLC19A2 mutations causing TRMA.
|
28004468 |
2017 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Three siblings with thiamine-responsive megaloblastic anemia (TRMA) with a homozygous c.454delGGCATinsAT mutation in SLC19A2 are described.
|
28076318 |
2017 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China.
|
26839896 |
2016 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Our findings are the first report, to the best of our knowledge, on this novel nonsense mutation of hTHTR-1 causing TRMA in an Indian patient through functionally impaired thiamine transporter activity.
|
26549656 |
2016 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our findings are the first report, to the best of our knowledge, on this novel nonsense mutation of hTHTR-1 causing TRMA in an Indian patient through functionally impaired thiamine transporter activity.
|
26549656 |
2016 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Among children with diabetes diagnosed between 6 and 12months, 1 patient had an INS mutation and one patient was homozygous for an SLC19A2 mutation which confirmed a diagnosis of thiamine-responsive megaloblastic anaemia syndrome.
|
27329029 |
2016 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We present the first patient with TRMAS in Lithuania - a 3-year-old boy born to a non-consanguineous family with a novel homozygous SLC19A2 gene mutation.
|
25707023 |
2015 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here we describe for the first time Leber's congenital amaurosis as the retinal phenotype and also report a novel point mutation in the SLC19A2 gene that co-segregated with the disease in a TRMA patient.
|
23638917 |
2014 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The SLC19A2 gene on chromosome 1q 23.3 is implicated in all cases with TRMA.
|
24249281 |
2014 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the thiamine transporter gene, solute carrier family 19, member 2 (SLC19A2), have been associated with TRMA.
|
24072090 |
2013 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.
|
22576805 |
2012 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Thiamine-responsive megaloblastic anaemia (TRMA), due to mutations in the thiamine transporter SLC19A2, is associated with the classical clinical triad of diabetes, deafness, and megaloblastic anaemia.
|
22369132 |
2012 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
|
19643445 |
2009 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
|
18614593 |
2009 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation.
|
17463047 |
2007 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
|
17659067 |
2007 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Mutations in the gene coding for the high-affinity thiamine transporter Slc19a2 underlie the clinical syndrome known as thiamine-responsive megaloblastic anemia (TRMA) characterized by anemia, diabetes, and sensorineural hearing loss.
|
16642288 |
2006 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is the association of diabetes mellitus, anaemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein.
|
16373304 |
2006 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
|
17132746 |
2006 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier, Tht1. A new insight into the critical role of thiamin in spermatogenesis.
|
14738878 |
2004 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report an African-American female with TRMA-syndrome associated with thyroid disease and retinitis pigmentosa caused by a novel mutation in the SLC19A2 gene.
|
14994241 |
2004 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
To study the role of thiamine transport in the pathophysiology of TRMA syndrome and of each of the component disorders, we created a targeted disruption of the Slc19a2 gene in mice.
|
14567973 |
2004 |
Thiamine responsive megaloblastic anemia syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family.
|
14622275 |
2003 |